Clinical Trials
9
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
- First Posted Date
- 2021-07-01
- Last Posted Date
- 2021-07-01
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 440
- Registration Number
- NCT04948151
- Locations
- 🇺🇸
Coastal Clinical Research, Mobile, Alabama, United States
🇺🇸Precision Clinical Trials-Arizona, Phoenix, Arizona, United States
🇺🇸Visions Clinical Research -Tucson, Tucson, Arizona, United States
Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness (DOMS)
- Conditions
- Delayed Onset Muscle Soreness, DOMS
- Interventions
- Drug: SST-0225Drug: Placebo
- First Posted Date
- 2015-11-05
- Last Posted Date
- 2016-10-13
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 156
- Registration Number
- NCT02597634
- Locations
- 🇺🇸
Site #203, Hollywood, Florida, United States
🇺🇸Site #201, South Miami, Florida, United States
🇺🇸Site #202, Springfield, Missouri, United States
Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2017-10-03
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 31
- Registration Number
- NCT02570282
- Locations
- 🇺🇸
The Sexual Psychophysiology Laboratory, Austin, Texas, United States
Phase 2a Topical Sildenafil Proof-of-Concept Study in Men With Mild to Moderate ED
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2015-03-18
- Last Posted Date
- 2017-10-12
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 33
- Registration Number
- NCT02390960
- Locations
- 🇺🇸
San Diego Sexual Medicine, San Diego, California, United States
🇺🇸Tulane Medical Center, New Orleans, Louisiana, United States
🇺🇸Manhattan Medical Research, New York, New York, United States
A Open-Label, Within-Subject Dose-Escalation Study to Evaluate the Clinical Safety and Pharmacokinetic Profile of a Topical Sildenafil Cream (5% w/w), in Healthy Postmenopausal Women
- First Posted Date
- 2015-02-18
- Last Posted Date
- 2015-06-22
- Lead Sponsor
- Strategic Science & Technologies, LLC
- Target Recruit Count
- 21
- Registration Number
- NCT02364882
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, Inc., Miami, Florida, United States
- Prev
- 1
- 2
- Next